SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-005938
Filing Date
2023-01-24
Accepted
2023-01-23 19:07:32
Documents
9

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm233924d1_sc13da.htm SC 13D/A 44362
2 EXHIBIT 3 tm233924-ex3.htm EX-3 33583
3 GRAPHIC tm233924-ex3img1.jpg GRAPHIC 237401
4 GRAPHIC tm233924-ex3img2.jpg GRAPHIC 383018
5 GRAPHIC tm233924-ex3img3.jpg GRAPHIC 116629
6 GRAPHIC tm233924-ex3img4.jpg GRAPHIC 779840
7 GRAPHIC tm233924-ex3img5.jpg GRAPHIC 808091
8 GRAPHIC tm233924-ex3img6.jpg GRAPHIC 288571
9 GRAPHIC tm233924-ex3img7.jpg GRAPHIC 142851
  Complete submission text file 0001104659-23-005938.txt   3876106
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 23545543
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Filed by) CIK: 0001728916 (see all company filings)

Type: SC 13D/A